HZHuayan Zhang

Huayan Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Huayan Zhang has a total of 274 co-authors. Here are the top co-authors by number of shared publications:

  • Ge Yang

    Division of Neonatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong, China

    4 shared publications
  • Haresh Kirpalani

    The Children's Hospital of Philadelphia Division of Neonatology

    4 shared publications
  • Kathleen Nilan

    The Children's Hospital of Philadelphia Division of Neonatology

    4 shared publications
  • Yuan Yuan

    Division of Neonatology and Center for Newborn Care, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China

    4 shared publications
  • Chunxiao Fang

    Department of Pediatric, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China

    3 shared publications
  • Fan Li

    Division of Neonatology and Center for Newborn Care, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China

    3 shared publications

Latest Publications

  • Open Access

    Integrative transcriptomic and functional profiling reveals neutrophil-associated immune dysregulation in bronchopulmonary dysplasia

    by Sen Li, Shunyu Xie, Haoying Huang, Haixia Chen, Meiling Zhou, Wenhao Zhou, Huayan Zhang, Xiaohui Wang

  • Open Access

    Gut dysbiosis modulates hyperoxia-induced bronchopulmonary dysplasia by promoting EMT through activating TLR4/NF-κB pathway

    by Yaqin Yan, Shuling Liang, Sen Li, Shunv Xie, Xiaohui Wang, Huayan Zhang

    Background: Bronchopulmonary dysplasia (BPD) is a major cause of morbidity and mortality in premature infants. Although gut microbial dysbiosis is implicated in BPD pathogenesis, the underlying mechanisms are poorly defined. This study aims to elucidate the specific pathway through which gut dysbiosis drives BPD pathology and to identify potential therapeutic targets. Methods: The experimental BPD model was established by hyperoxia (FiO 2 85%) in neonatal mice from postnatal days 1 to 14. Pulmonary alveolarization and inflammation were analyzed at postnatal day 15. The modulatory role of gut microbiota was assessed using antibiotic-induced dysbiosis and fecal microbiota transplantation (FMT) from normoxic mice. Gut microbiome analysis was performed using 16S rRNA gene sequencing. The specific signaling pathway was investigated using a pharmacological inhibitor of TLR4. Furthermore, the molecular mechanisms were investigated through western blotting, real-time quantitative PCR, ELISA, and immunofluorescence. Results: Hyperoxia exposure induced impaired alveolarization, disrupted gut barrier integrity, and gut dysbiosis. These pathological changes were accompanied by elevated pulmonary inflammation, potent activation of the TLR4/NF-κB pathway, and upregulation of epithelial-mesenchymal transition (EMT) associated markers. These changes were exacerbated by early postnatal antibiotic administration, whereas FMT from normoxic mice rescued these phenotypes, restored gut barrier function, suppressed TLR4/NF-κB signaling, and reversed EMT progression. Notably, pharmacological inhibition of TLR4 mirrored the protective effects of FMT, effectively attenuating hyperoxia-induced lung injury and EMT. Conclusions: Our findings establish a mechanistic link for the gut-lung axis in BPD, demonstrating that gut dysbiosis is a critical modulator of lung development impairment and pathological EMT via activation of the TLR4/NF-κB pathway.

  • Open Access

    CQMUH-011 mitigated LPS-induced acute lung injury in neonatal rabbits

    by Yaling Xu, Xiaojing Guo, Xiao Han, Xiangnan Hu, Bin Gao, Bo Sun, Huayan Zhang

    The online version contains supplementary material available at 10.1038/s41598-026-49167-x.

  • Open Access

    Variations in bronchopulmonary dysplasia prevalence and outcomes by definition: a multicentre cohort study from the Chinese Neonatal Network

    by Ge Yang, Ling Wang, Cuizhen Gao, Wenli Li, Fangping Zhao, Yun Cao, Wenhao Zhou, LiZhong Du, Chao Chen, Shoo K Lee, et al.

    Objectives: To examine bronchopulmonary dysplasia (BPD) epidemiological data in Chinese very preterm infants and compare agreement between four diagnostic definitions and their predictive accuracy for discharge outcomes. Design: Observational epidemiologic study of a multicentre cohort of the Chinese Neonatal Network (CHNN). Setting: Tertiary neonatal intensive care units participating in the CHNN. Participants: 42 664 preterm infants born at <32 weeks’ gestational age from 2019 to 2023. Measures: BPD was diagnosed using four definitions: Shennan 1988, the National Institute of Child Health and Human Development (NICHD) 2001 and 2018, and the Neonatal Research Network (NRN) 2019 definitions. BPD prevalence and severity were examined. Agreement was assessed using kappa statistics. Predictive accuracy for discharge outcomes was evaluated using c-statistics from multivariable generalised estimating equation models. Results: Among 42 664 infants (mean gestational age, 29.0 weeks; 43.1% females), BPD prevalence varied significantly: Shennan 1988: 37.0%, NICHD 2001: 51.1%, NICHD 2018: 37.0%, NRN 2019: 37.0%. NICHD 2001 and 2018 definitions classified more infants as severe BPD (16.4% and 10.1%, respectively), while NRN 2019 classified more as grade 2 (moderate; 15.0%). Shennan 1988 showed good agreement with NICHD 2018 (κ=1.0) and Jensen 2019 (κ=1.0). Shennan 1988 (c-statistic range: 0.921–0.974), NICHD 2018 (0.948-0.978) and NRN 2019 (0.949-0.982) demonstrated higher discriminative accuracy for discharge outcomes than NICHD 2001 (0.854–0.925). Conclusions: This study found a high prevalence of BPD among very preterm infants in China, varying by definitions. The Shennan 1988, NICHD 2018 and NRN 2019 definitions showed good agreement and better predictive accuracy for outcomes at discharge compared with NICHD 2001. These definitions could be prioritised for clinical use in our population.


  • Open Access

    The prediction of phototherapy by early postnatal ETCOc in Chinese newborns

    by Ge Yang, Li Deng, Kun Zhang, Huijuan Liu, Xinrui Fu, Yue Hu, Xiaodan Yan, Xiaoyun Zhou, Wei Luo, Siyao Wang, et al.

    The clinical significance of early postnatal ETCOc in the prediction of phototherapy (PT) for neonatal hyperbilirubinemia has not been fully characterized.


  • Open Access

    Author Correction: Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

    by Yi Xu, Xufang Li, Bing Zhu, Huiying Liang, Chunxiao Fang, Yu Gong, Qiaozhi Guo, Xin Sun, Danyang Zhao, Jun Shen, et al.


  • Open Access

    Neonatal early-onset sepsis caused by Streptococcus Gallolyticus subsp. Pasteurianus with severe pulmonary hypertension and leukemoid reaction: a case report

    by Xuelian Wang, Ling Wang, Yuan Yuan, Xiaopeng Zhao, Huayan Zhang

    Streptococcus gallolyticus subsp. pasteurianus (SGSP) is an uncommon cause of neonatal early-onset sepsis (EOS). We present a case of neonatal EOS attributed to SGSP in an infant complicated by meconium aspiration syndrome (MAS) and congenital pneumonia. The infant developed severe pulmonary hypertension and exhibited a leukemoid reaction during recovery. The clinical features of this case are rare, and a comprehensive review of her peripartum and follow-up data could enhance our understanding of this organism. This is a full-term female neonate born to a healthy mother via cesarean section due to suspected fetal distress with meconium-stained amniotic fluid. She required resuscitation in the delivery room and was subsequently admitted to the neonatal intensive care unit for respiratory distress. Both the mother and the baby exhibited fever after delivery, and cultures from the baby’s blood and amniotic fluid revealed the same strain of SGSP. The baby had MAS and developed severe pulmonary hypertension, which was successfully treated with a comprehensive approach that included ampicillin, high-frequency oscillatory ventilation, inhaled nitric oxide, fluid resuscitation, and vasopressors. A significant increase in the white blood cell count was noted during her clinical improvement, followed by a spontaneous decline. The baby completed a 12-day course of ampicillin and was followed up to 1 year of age, during which she thrived. A systematic literature review on early-onset SGSP sepsis was also conducted. SGSP infection can be associated with life-threatening complications. This case underscores the importance of considering SGSP as a potential etiology in neonatal EOS.

  • Open Access

    End-tidal CO corrected for ambient CO risk adjusted phototherapy threshold for the management of neonatal hyperbilirubinemia: a randomized clinical trial

    by Ge Yang, Li Deng, Kun Zhang, Hui-Juan Liu, Xin-Rui Fu, Yue Hu, Xiao-Dan Yan, Xiao-Yun Zhou, Wei Luo, Si-Yao Wang, et al.

    Background: Neonatal hyperbilirubinemia risk factors determination is challenging due to the lack of quantifiable indicators for bilirubin production, resulting in phototherapy decisions made without real-time information. End-tidal carbon monoxide (CO) corrected for ambient CO (ETCOc) may be helpful for identifying hemolysis, but evidence on the application of ETCOc as a risk factor for the development of neonatal hyperbilirubinemia is scarce. This study aimed to evaluate whether the use of ETCOc to adjust neonatal hyperbilirubinemia risk categories and thus phototherapy thresholds can reduce the rate of phototherapy within the first seven days of life. Methods: This is a randomized clinical trial including near-term and term infants with a transcutaneous bilirubin $$>$$ > 40th percentile within 72 hours after birth in a single center in Guangdong, China. Newborns were randomized to receive ETCOc-adjusted risk assessment or empirical assessment per local practice to establish phototherapy thresholds. The primary outcome was the rate of phototherapy within seven days of life. Secondary outcomes were postnatal hours at phototherapy, total serum bilirubin and ETCOc before phototherapy, severe hyperbilirubinemia and phototherapy duration. Results: A total of 2500 infants were enrolled and randomized. Phototherapy within seven days of life occurred in 237 infants (18.9%) in the intervention group and 281 infants (22.5%) in the control group [adjusted relative risk: 0.85; 95% confidence interval (CI): 0.73, 0.98]. The ETCOc before phototherapy was 0.28 parts per million higher (95% CI: 0.10, 0.46) in the intervention group. The rate of subsequent severe hyperbilirubinemia was not significantly different, and other secondary outcomes were comparable between the two groups. Conclusions: For near-term and term infants at risk of neonatal hyperbilirubinemia, the use of ETCOc to adjust neonatal hyperbilirubinemia risk categories can decrease the rate of phototherapy at seven days of life. Integrating the ETCOc to adjust the phototherapy threshold is helpful in the management of severe hyperbilirubinemia. Graphical


  • End-tidal carbon monoxide levels as a point-of-care biomarker for the early detection of hemolytic disease in Chinese neonates

    by Ge Yang, Kun Zhang, Li Deng, Huijuan Liu, Xinrui Fu, Yue Hu, Xiaodan Yan, Xiaoyun Zhou, Wei Luo, Siyao Wang, et al.


  • Open Access

    Review of: "Annealed Stein Variational Gradient Descent for Improved Uncertainty Estimation in Full-Waveform Inversion"

    by Huayan Zhang

    A new improvement of the Stein Variational Gradient Descent is proposed in the paper. The experimental results are sufficient and persuasive. The authors use Principal Component Analysis and clustering techniques to evaluate the performance of the op...